课题基金 / 基金详情

Establishment of gene therapy for the regulation of IgE and Chemokine production in patients with nasal allergy

Establishment of gene therapy for the regulation of IgE and Chemokine production in patients with nasal allergy
建立调节鼻过敏患者 IgE 和趋化因子产生的基因疗法
批准号:
13470359
负责人:
FUJIEDA Shigeharu
金额:
$9.09万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003

项目摘要

项目成果

FUJIEDA Shigeharu的其他基金

相似基金

相关文献

中文摘要
翻译
鼻成纤维细胞在细胞因子的刺激下释放趋化因子,在变应性鼻炎的发病中起重要作用。Syk蛋白在人鼻成纤维细胞中有表达,但表达水平不同。Syk蛋白表达水平与LPS诱导RANTES的产生呈正相关。通过基因转移过表达野生型Syk可促进RANTES的产生,而Syk反义核酸可抑制RANTES的产生。JNK 1和p38 MAP激酶对RANTES的产生是重要的。制备了四种显性阳性突变型Ras,并转染鼻成纤维细胞。Ras突变体激活PI 3激酶通路后,鼻成纤维细胞产生最多的RANTES,双链RNA(dsRNA)也能诱导鼻成纤维细胞产生RANTES,IFNg的加入能促进dsRNA产生RANTES,而IL 4对RANTES的产生无促进作用,dsRNA不诱导Eotaxin的产生。而IL-4和deRNA对鼻成纤维细胞Eotaxin的产生有协同作用。鼻成纤维细胞表达CCR 3,建立了一种新的定量IgE类转换的方法,人IgG-IgE嵌合蛋白通过与人IgG-IgE嵌合蛋白共表达抑制IgE类转换,并通过与人IgG-IgE嵌合蛋白共表达抑制IgE类转换,从而抑制IgE类转换。聚集B细胞CD 32和CD 23。该蛋白直接抑制生殖系转录、随后的类转换和IgE的产生。
英文摘要
Nasal fibroblasts stimulated by cytokines released the chemokine and play a key role in pathogenesis of allergic rhinitis.Syk proteins were expressed in human nasal fibroblasts, but the expression level varied.There were positive correlation between the level of Syk expression and RANTES production by LPS.Over expression of wild-type Syk by gene transfer enhanced RANTES production.Administration of Syk-antisense inhibited RANTES production. JNK1 and p38 MAP kinase are important for RANTES production. Four types of dominant positive mutant Ras were made and transfected into nasal fibroblast. When PI3kinase pathway was activated by Ras mutant, nasal fibroblast produced the largest amount of RANTES.Double strand RNA(dsRNA) also induced RANTES production by nasal fibroblast.The addition of IFNg enhanced RANTES production by dsRNA, while IL4 had no effect to enhance RANTES production.Eotaxin was not induced by dsRNA. However, IL-4 and deRNA had syngergistic effect to induce Eotaxin production by nasal fibroblst. Nasal fibroblast expressed CCR3, which is a regand to RANTES and Eotaxin.The treatment of RANTES increased CCR 3 expression on nasal fibroblast and induced cell growth in the manner of autocrine.CD45 molecules regulated IgE class switching on B cells via JNK pathway.The new method to quantify IgE class swithing was established.Human IgG-IgE chimeric protein inhibit IgE class switch recombination by co-aggregating B cell CD32 and CD23.This protein directly inhibited germline transcription, subsequent class switching to and IgE production.
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
Yamada, T., et al.: "CD45 controls interleukin-4-mediated IgE class switch recombination in human B cells through its Function as a Janus kinase phosphatase."J.Biol.Chem.. 277. 28830-28835 (2002)
Yamada, T. 等人:“CD45 通过其作为 Janus 激酶磷酸酶的功能控制人 B 细胞中白细胞介素 4 介导的 IgE 类别转换重组。”J.Biol.Chem.. 277. 28830-28835 (2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
藤枝 重治 他: "鼻線維芽細胞におけるケモカイン産生と増殖シグナルについて"日本鼻科学会会誌. 42(1). 1-7 (2003)
Shigeharu Fujieda 等人:“鼻成纤维细胞中的趋化因子产生和增殖信号”日本鼻学会杂志 42(1) 1-7 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamada T, Fujieda S, et al.: "Protein-tyrosine Syk expressed in human nasal fibroblasts"J.Immunol.. 166. 538-543 (2001)
Yamada T、Fujieda S 等:“在人鼻成纤维细胞中表达的蛋白质-酪氨酸 Syk”J.Immunol.. 166. 538-543 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yamada, T., et al.: "Inhibition of IL-4-induced class switch recombination by a human Ig Fcγ -Fcε chimeric protein."J.Biol.Chem.. 278. 32818-32824 (2003)
Yamada, T., 等人:“人 Ig Fcγ -Fcε 嵌合蛋白对 IL-4 诱导的类别转换重组的抑制。J.Biol.Chem.. 278. 32818-32824 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 17 条
    Prevent and therapeutic strategy bycombination of microarray and proteomics for seasonal allergic rhinitis caused by Japanese cedar pollen.
    • 批准号:
      23390397
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.23万
    • 财政年份:
      2011
    • 负责人:
      FUJIEDA Shigeharu
    • 依托单位:
    New strategy for seasonal allergic rhinitis by exosomes
    • 批准号:
      22659306
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.01万
    • 财政年份:
      2010
    • 负责人:
      FUJIEDA Shigeharu
    • 依托单位:
    The development of a new therapeutic moleculefor Japanese cedar pollinosis by proteomics analysis in the serum of patients treated with sublingual immunotherapy
    • 批准号:
      20390441
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.65万
    • 财政年份:
      2008
    • 负责人:
      FUJIEDA Shigeharu
    • 依托单位:
    Analysis of allergic rhinitis by nano level and development of novel therapy
    • 批准号:
      17390458
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.58万
    • 财政年份:
      2005
    • 负责人:
      FUJIEDA Shigeharu
    • 依托单位:
    国内基金
    海外基金
    金荞麦黄酮靶向抑制c-MET介导的PI3K/Akt和Ras/MAPK通路逆转NSCLC EGFR-TKI耐药的机制研究
    • 批准号:
      2026JJ81256
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      李弘德
    • 依托单位:
    槲皮素基于P53/Ras调控细胞凋亡增殖抗OSF癌变的机制研究
    • 批准号:
      2026JJ82512
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王韧
    • 依托单位:
    lncRNA H19通过介导Ras/ULK1信号影响乳腺癌细胞线粒体稳态及糖酵解的作用及机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      施文标
    • 依托单位:
    新型污染物三(2-氯丙基)磷酸酯通过RAS/NLRP3信号通路致肾纤维化机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      李升
    • 依托单位: